10x Genomics, Inc. TXG Accrued Progress Collections and Price Adjustments
Accrued Progress Collections and Price Adjustments at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s accrued progress collections and price adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s accrued progress collections and price adjustments?
- 10x Genomics, Inc. (TXG) reported accrued progress collections and price adjustments of $10.14M in Q1 2026.
- How has 10x Genomics, Inc.'s accrued progress collections and price adjustments changed year-over-year?
- 10x Genomics, Inc.'s accrued progress collections and price adjustments decreased by 19.3% year-over-year, from $12.57M to $10.14M.
- What is the long-term trend for 10x Genomics, Inc.'s accrued progress collections and price adjustments?
- Over 3 years (2022 to 2025), 10x Genomics, Inc.'s accrued progress collections and price adjustments has grown at a 49.1% compound annual growth rate (CAGR), from $3.17M to $10.5M.